[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2019 Pilocytic Astrocytoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 52 pages | ID: 27A05D9094AEN
VPAResearch

US$ 1,619.00 US$ 1,799.00 -10 %
Offer valid until December 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global clinical trial report- “2019 Pilocytic Astrocytoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pilocytic Astrocytoma. It presents in-depth analysis of Pilocytic Astrocytoma clinical trials across markets and companies. The research work is for providing complete understanding into trends in Pilocytic Astrocytoma.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Pilocytic Astrocytoma clinical trials by-
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Pilocytic Astrocytoma

The research work is prepared through extensive and continuous research on Pilocytic Astrocytoma trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Pilocytic Astrocytoma patients are identified
  • The report includes panorama of Pilocytic Astrocytoma clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Pilocytic Astrocytoma clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Pilocytic Astrocytoma Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Pilocytic Astrocytoma Clinical Trials by Region
  2.2.2 Average Enrollment of Pilocytic Astrocytoma Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Pilocytic Astrocytoma Treatment, 2019

3. REGION WISE PILOCYTIC ASTROCYTOMA CLINICAL TRIALS

3.1 Asia Pacific Pilocytic Astrocytoma Clinical Trials by Country
3.2 Europe Pilocytic Astrocytoma Clinical Trials by Country
3.3 North America Pilocytic Astrocytoma Clinical Trials by Country
3.4 Middle East and Africa Pilocytic Astrocytoma Clinical Trials by Country
3.5 South and Central America Pilocytic Astrocytoma Clinical Trials by Country

4. PILOCYTIC ASTROCYTOMA CLINICAL TRIAL TRENDS

4.1 Start Year wise Pilocytic Astrocytoma Clinical Trials
4.2 Phase wise Pilocytic Astrocytoma Clinical Trials
4.3 Trial Status wise Pilocytic Astrocytoma Clinical Trials
4.4 Trial Type wise Pilocytic Astrocytoma Clinical Trials

5. PILOCYTIC ASTROCYTOMA AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Pilocytic Astrocytoma Trials by Year
5.2 Average Enrollment in Pilocytic Astrocytoma Trials by Phase
5.3 Average Enrollment in Pilocytic Astrocytoma Trials by Status
5.4 Average Enrollment in Pilocytic Astrocytoma Trials by Type of Trial

6. COMPANIES PARTICIPATING IN PILOCYTIC ASTROCYTOMA CLINICAL TRIALS

6.1 Pilocytic Astrocytoma Trials by Sponsor Type
6.2 Pilocytic Astrocytoma Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Pilocytic Astrocytoma Trials- Phase
7.2 Pilocytic Astrocytoma Trials- Phase
7.3 Pilocytic Astrocytoma Trials- Phase
7.4 Pilocytic Astrocytoma Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

LIST OF FIGURES

Figure 1: Pilocytic Astrocytoma Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Pilocytic Astrocytoma Clinical Trials and Enrolment
Figure 5: Europe – Country wise Pilocytic Astrocytoma Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Pilocytic Astrocytoma Clinical Trials and Enrolment
Figure 7: North America – Country wise Pilocytic Astrocytoma Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Pilocytic Astrocytoma Clinical Trials and Enrolment
Figure 9: Pilocytic Astrocytoma Clinical Trials by Phase
Figure 10: Pilocytic Astrocytoma Clinical Trials by Trial Status
Figure 11: Pilocytic Astrocytoma Clinical Trials by Type
Figure 12: Pilocytic Astrocytoma Clinical Trials by Sponsor Type
Figure 13: Pilocytic Astrocytoma Clinical Trials by Leading Sponsors
Figure 14: Pilocytic Astrocytoma Average Enrollment by Phase
Figure 15: Pilocytic Astrocytoma Average Enrollment by Trial Status
Figure 16: Pilocytic Astrocytoma Average Enrollment by Type
Figure 17: Pilocytic Astrocytoma- Average Enrolment by Type of Sponsors
Figure 18: Pilocytic Astrocytoma- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

LIST OF TABLES

Table 1: Pilocytic Astrocytoma Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Pilocytic Astrocytoma Clinical Trials and Enrolment
Table 5: Europe – Country wise Pilocytic Astrocytoma Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Pilocytic Astrocytoma Clinical Trials and Enrolment
Table 7: North America – Country wise Pilocytic Astrocytoma Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Pilocytic Astrocytoma Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Pilocytic Astrocytoma Average Enrollment by Phase
Table 15: Pilocytic Astrocytoma Average Enrollment by Trial Status
Table 16: Pilocytic Astrocytoma Average Enrollment by Type
Table 17: Pilocytic Astrocytoma- Average Enrolment by Type of Sponsors
Table 18: Pilocytic Astrocytoma- Enrolment by Leading Sponsors


More Publications